secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2021-10-29T23:59:59+00:00
Accession:  0001493152-21-026723
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exactus renamed Panacea Life Sciences; 1-for-28 reverse split; Series C-2 preferred issued to cancel 205M shares
--------------------------------------------------------------------------------

- Company changed name to Panacea Life Sciences Holdings, Inc., effective Oct 25, 2021.
- Effected 1-for-28 reverse stock split of common stock.
- Designated 100 shares of Series C-2 Convertible Preferred stock, each convertible into 2,050,000 common shares.
- Issued all 100 Series C-2 shares to Quintel-MC Inc., owned by CEO Leslie Buttorff, in exchange for canceling 205,000,000 common shares.
- CEO Leslie Buttorff is sole owner, officer, and director of Quintel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221026723/0001493152-21-026723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221026723/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-026723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer